[Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases].
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis*; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology / Q000276:immunology*; D005260:Female; D006016:Glycolates / Q000009:adverse effects*; D006801:Humans; D007565:Jaundice / Q000139:chemically induced / Q000175:diagnosis; D007668:Kidney / Q000276:immunology*; D008099:Liver / Q000473:pathology; D008297:Male; D008861:Microsomes / Q000276:immunology*; D008862:Microsomes, Liver / Q000276:immunology*; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D013989:Ticrynafen / Q000009:adverse effects*; D013997:Time Factors
D000906:Antibodies; D006016:Glycolates; D013989:Ticrynafen
Atteintes hépatiques associées aux anticorps antimicrosomes de foie et de rein (type 2) et a la prise d'acide tiénilique. Une étude de 37 cas.